Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.18%177.06M | -7.28%163.07M | -0.16%184.19M | -0.27%753.09M | 1.19%206M | 8.50%186.72M | -1.21%175.88M | -8.41%184.5M | -9.97%755.14M | -0.11%203.58M |
| Cost of revenue | -0.88%687.41M | -11.19%693.53M | ||||||||
| Gross profit | 6.61%65.68M | 6.54%61.6M | ||||||||
| Operating expense | -6.05%171.57M | -7.80%160.35M | 0.66%181.94M | -0.67%48.53M | 0.65%200.3M | 6.48%182.63M | -1.25%173.91M | -9.16%180.74M | 4.67%48.86M | 134.07%199M |
| Staff costs | ---- | ---- | ---- | 6.14%31.2M | ---- | ---- | ---- | ---- | 3.37%29.4M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | -11.97%4.05M | ---- | ---- | ---- | ---- | 4.76%4.6M | ---- |
| -Depreciation | ---- | ---- | ---- | -11.97%4.05M | ---- | ---- | ---- | ---- | 4.76%4.6M | ---- |
| Other operating expenses | -6.12%173.78M | -8.17%161.95M | -0.60%182.85M | -5.75%15.77M | 1.11%202.4M | 7.05%185.1M | -0.62%176.35M | -8.41%183.95M | -7.93%16.73M | 132.40%200.17M |
| Total other operating income | -10.77%2.21M | -34.52%1.6M | -71.59%911K | 33.17%2.49M | 79.25%2.11M | 76.87%2.48M | 81.92%2.45M | 71.96%3.21M | -56.73%1.87M | 249.62%1.18M |
| Operating profit | 33.96%5.48M | 38.10%2.72M | -40.03%2.25M | 34.54%17.15M | 24.32%5.7M | 608.13%4.09M | 2.76%1.97M | 51.96%3.75M | 14.40%12.75M | -34.67%4.58M |
| Net non-operating interest income (expenses) | -101.21%-1.16M | 63.08%-374K | 16.07%-449K | 60.16%1.21M | 22.71%-456K | -25.43%-577K | -123.13%-1.01M | -109.80%-535K | 267.33%758K | -104.15%-590K |
| Non-operating interest income | ---- | ---- | ---- | 50.81%3.8M | ---- | ---- | ---- | ---- | --2.52M | ---- |
| Non-operating interest expense | 101.21%1.16M | -63.08%374K | -16.07%449K | 46.79%2.58M | -22.71%456K | 25.43%577K | 123.13%1.01M | 109.80%535K | 288.30%1.76M | 104.15%590K |
| Net investment income | -95.39%407K | 2,196.88%8.82M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -6,442.98%-7.92M | -228.46%-1.17M | -812.99%-549K | 1,087.91%899K | -94.83%33K | -168.75%-121K | 220.85%910K | 150.66%77K | 97.81%-91K | 136.52%638K |
| Special income (charges) | 13.89%-5.12M | 0 | -40.16%-5.95M | 8.59M | ||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | -215.48%-530K | ---- | ---- | ---- | ---- | ---168K | ---- |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.59M | ---8.59M |
| Less:Write off | ---- | ---- | ---- | -7.59%5.65M | ---- | ---- | ---- | ---- | 44.12%6.12M | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -205.89%-3.6M | -36.88%1.18M | -61.99%1.25M | -10.68%14.55M | -60.08%5.28M | 1,054.76%3.4M | 162.73%1.87M | 59.75%3.29M | 507.42%16.29M | 1,078.07%13.22M |
| Income tax | 30.93%889K | -1.17%677K | -53.13%442K | 37.10%3.75M | 179.07%1.44M | 30.08%679K | -6.80%685K | -1.77%943K | 31.39%2.73M | 218.62%516K |
| Net income | -265.10%-4.48M | -57.57%502K | -65.55%810K | -20.31%10.8M | -69.80%3.84M | 1,291.23%2.72M | 5,029.17%1.18M | 113.34%2.35M | 2,154.91%13.55M | 715.80%12.7M |
| Net income continuous operations | -265.10%-4.48M | -57.57%502K | -65.55%810K | -20.31%10.8M | -69.80%3.84M | 1,291.23%2.72M | 5,029.17%1.18M | 113.34%2.35M | 2,154.91%13.55M | 715.80%12.7M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 98.28%-1K | 0 | |||
| Net income attributable to the company | -265.10%-4.48M | -57.57%502K | -65.55%810K | -20.32%10.8M | -69.80%3.84M | 1,291.23%2.72M | 5,243.48%1.18M | 113.34%2.35M | 1,956.60%13.55M | 716.85%12.7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -265.10%-4.48M | -57.57%502K | -65.55%810K | -20.32%10.8M | -69.80%3.84M | 1,291.23%2.72M | 5,243.48%1.18M | 113.34%2.35M | 1,956.60%13.55M | 716.85%12.7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -265.55%-0.0197 | -57.69%0.0022 | -65.05%0.0036 | -20.34%0.0474 | -69.89%0.0168 | 1,290.00%0.0119 | 5,300.00%0.0052 | 114.58%0.0103 | 1,951.72%0.0595 | 720.59%0.0558 |
| Diluted earnings per share | -265.55%-0.0197 | -57.69%0.0022 | -65.05%0.0036 | -20.34%0.0474 | -69.89%0.0168 | 1,290.00%0.0119 | 5,300.00%0.0052 | 114.58%0.0103 | 1,951.72%0.0595 | 720.59%0.0558 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.